Loading...
Last update:  December 3, 2017
19:22 +1GMT

Allergenic Molecule  Fel d 1Felis domesticusHomo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640820.06020100301, Scala E
3.2.1 - Source Sensitized (IgE)1999NetherlandsIgE50996.100
6.2 - General Population (Adults)2012SwedenIgE3714.85020120528, Patelis A
5.1.1 - Source Exposed (Symptoms)2005New ZealandIgE19913.100
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14035.71020130111, Ott H
1.4 - Respiratory Symptoms, Diagnosed2005GermanyIgE13217.400
1.5 - Atopic Dermatitis, Diagnosed2005GermanyIgE11319.500
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9948.48020110223, De Knop KJ
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9627.08020120528, Patelis A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8620.93020101214, Gadisseur R
5.3.1 - Source Exposed (Symptoms, IgE)2014AustraliaIgE8677.91020140225, Hales BJ
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7630.30020131020, van Rhijn BD
5.2.2 - Source Exposed, Adults (Symptoms, SPT)2008Austria / SwedenIgE7294.44020080512, Gronlund H
5.2.3 - Source Exposed, Children (Symptoms, SPT)2008Austria / SwedenIgE6895.59020080512, Gronlund H
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5442.90020120310, Twaroch TE
1.1 - Asymptomatic2011ZimbabweIgE470.00020110307, Arkestal K
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2013United StatesIgE4520.00020130409, Kennedy JL
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3759.45020090826, Ebo DG
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE3789.00020140127, Konradsen JR
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3525.71020130605, Simon D
4.1.5 - Heterologous Source Sensitized (IgE)2013LuxembourgIgE3551.43020131227, Hilger C
5.3.1 - Source Exposed (Symptoms, IgE)2011ZimbabweIgE3174.19020110307, Arkestal K
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE2886.00020140127, Konradsen JR
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2004AustraliaIgE2788.900
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE2642.30020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2231.82020091121, Ebo DG
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2065.00020091005, Ott H
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2040.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2013United StatesIgE7100.00020130128, Posthumus J
Developed by
Panservice